General Updates
Deal
Deal value—
Deal vs business2.2 GW cell plant backward integration supporting ₹2,346 Cr TTM module base
Execution period1.5 yr
Fundamental gradeB
AI projections
Revenue uplift (yr1 / steady)18.0% / 35.0%
EPS uplift28.0%
Upside base / bull / bear45.0% / 95.0% / -25.0%
Horizon12-24 months
Realized market record
Entry — next-day open—
Latest close (02 Sep 2026)₹866.85
Return since—
α vs Smallcap 250—
α vs own sectorshown once held 90+ days — Electric Equipment median is -15.8% over 53 matured picks
Positives
- Backward integration into 2.2 GW TOPCon cells captures margin stack and reduces third-party cell reliance.
- Strong trailing financials with ROCE at 44.0% and TTM PAT of ₹200 Cr on ₹2,346 Cr revenue.
- Supportive macro environment with ALMM/DCR mandates driving domestic solar cell demand.
- Undemanding valuation at ~11.1x trailing P/E compared to electric equipment peer median of 57.3x.
Risks
- Inauguration was already telegraphed in August 2026 filings/concalls (priced in as near-term news).
- High debt of ₹535 Cr (D/E 0.95) following capex, which compressed Q1 FY27 PAT due to rising finance costs.
- Technological obsolescence and intense competition from domestic tier-1 peers (Waaree, Adani) and global price dumping.
Full AI brief
1. Industry Context & Execution Dynamics
Solar cell manufacturing is highly capital-intensive and technologically demanding. Ramping a 2.2 GW G12R TOPCon line involves intricate yield optimization, cleanroom environmental controls, and wafer sourcing. The Indian solar sector is projected to expand at a 20-25% CAGR backed by ALMM mandates and domestic content requirements (DCR).
2. Ramp-Aware Catalyst Impact Math
- Nature of Announcement: Confirmation of commercial inauguration on September 16, 2026 for the 2.2 GW cell plant (previously flagged in August 2026 earnings calls).
- Revenue & Margin Uplift:
- Year 1 (FY27): Gradual capacity utilization ramp (40-50% utilization) primarily displacing imported/third-party cell purchases and adding incremental captive value. Revenue uplift estimated at ~18% (to ~₹2,750 Cr).
- Steady State (FY28+): 80%+ utilization of 2.2 GW cell lines enhances integrated EBITDA margins by 200-300 bps (to ~16-17%), enabling consolidated revenue to scale toward ₹3,150 Cr (+35% over TTM) and steady-state PAT toward ₹260-280 Cr (+30-40% over TTM ₹200 Cr).
- EPS Impact: Steady-state EPS expansion to ~₹100-108/share (vs TTM ₹78.34).
3. Multibagger Quality Checklist
- EPS & Revenue Growth: FY26 delivered explosive revenue expansion (₹2,223 Cr vs ₹780 Cr in FY25), though Q1 FY27 net profit cooled slightly YoY (₹39.9 Cr vs ₹42.0 Cr) due to interest costs from ongoing capex.
- ROCE & Balance Sheet: High ROCE of 44.0% offsets debt of ₹535 Cr (D/E 0.95). Working capital intensity remains elevated.
- Promoter Alignment: Promoter holding stable and high at 65.9%.
4. Valuation & Calibrated Scenarios (Horizon: 18-24 Months)
- Base Case (+45%): Cell plant achieves 70% utilization in FY27/28; EPS reaches ₹95-100; P/E re-rates modestly to 12.5-13x -> Target Price ~₹1,250.
- Bull Case (+95%): Swift ramp to >85% utilization, domestic cell premium margins materialize, EPS reaches ₹115+ at a 15x multiple -> Target Price ~₹1,700.
- Bear Case (-25%): Yield stabilization issues, prolonged debt drag on PAT, global wafer price volatility squeeze margins -> Target Price ~₹650 (P/E 9x on ₹72 EPS).
5. Verdict Rationale
Alpex Solar presents strong fundamentals and significant margin expansion potential from backward integration into solar cells. However, because the plant commissioning was already outlined in mid-August filings, the immediate event is largely priced in, and execution/yield risks warrant a measured 'POSSIBLE' multibagger rating.
Analysis as of 2026-09-04 (price ₹866.85) ·
AI research, not investment advice.
